A predictive signature for therapy assignment and risk assessment in prostate cancer

Désirée Bonci; Ruggero De Maria Marchiano

doi:10.18632/oncoscience.271

A predictive signature for therapy assignment and risk assessment in prostate cancer

Désirée Bonci, Ruggero De Maria Marchiano

Istituto Superiore di Sanita

Risultato della ricerca: Contributo in rivista › Articolo in rivista

4 Citazioni (Scopus)

Abstract

Prostate cancer remains the second leading cause of death in men. It is imperative to improve patient management in identifying bio-markers for personalized treatment. We demonstrated miR-15/miR-16 loss and miR-21 up-regulation and deregulation of their target genes, which represent a promising signature for ameliorating therapy assignment and risk assessment in prostate cancer.

Lingua originale	English
pagine (da-a)	920-923
Numero di pagine	4
Rivista	Oncoscience
Volume	2
DOI	https://doi.org/10.18632/oncoscience.271
Stato di pubblicazione	Pubblicato - 2015

Keywords

Cancer Research
Genes
Non-coding RNA
Oncology
Prostrate cancer
miRNA

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.18632/oncoscience.271

Altri file e collegamenti

Cita questo

@article{c955422c986044f8bc7672f2d919295f,

title = "A predictive signature for therapy assignment and risk assessment in prostate cancer",

abstract = "Prostate cancer remains the second leading cause of death in men. It is imperative to improve patient management in identifying bio-markers for personalized treatment. We demonstrated miR-15/miR-16 loss and miR-21 up-regulation and deregulation of their target genes, which represent a promising signature for ameliorating therapy assignment and risk assessment in prostate cancer.",

keywords = "Cancer Research, Genes, Non-coding RNA, Oncology, Prostrate cancer, miRNA, Cancer Research, Genes, Non-coding RNA, Oncology, Prostrate cancer, miRNA",

author = "D{\'e}sir{\'e}e Bonci and {De Maria Marchiano}, Ruggero",

year = "2015",

doi = "10.18632/oncoscience.271",

language = "English",

volume = "2",

pages = "920--923",

journal = "Oncoscience",

issn = "2331-4737",

publisher = "Impact Journals LLC",

}

TY - JOUR

T1 - A predictive signature for therapy assignment and risk assessment in prostate cancer

AU - Bonci, Désirée

AU - De Maria Marchiano, Ruggero

PY - 2015

Y1 - 2015

N2 - Prostate cancer remains the second leading cause of death in men. It is imperative to improve patient management in identifying bio-markers for personalized treatment. We demonstrated miR-15/miR-16 loss and miR-21 up-regulation and deregulation of their target genes, which represent a promising signature for ameliorating therapy assignment and risk assessment in prostate cancer.

AB - Prostate cancer remains the second leading cause of death in men. It is imperative to improve patient management in identifying bio-markers for personalized treatment. We demonstrated miR-15/miR-16 loss and miR-21 up-regulation and deregulation of their target genes, which represent a promising signature for ameliorating therapy assignment and risk assessment in prostate cancer.

KW - Cancer Research

KW - Genes

KW - Non-coding RNA

KW - Oncology

KW - Prostrate cancer

KW - miRNA

KW - Cancer Research

KW - Genes

KW - Non-coding RNA

KW - Oncology

KW - Prostrate cancer

KW - miRNA

UR - http://hdl.handle.net/10807/112043

UR - http://www.impactjournals.com/oncoscience/files/papers/1/271/271.pdf

U2 - 10.18632/oncoscience.271

DO - 10.18632/oncoscience.271

M3 - Article

SN - 2331-4737

VL - 2

SP - 920

EP - 923

JO - Oncoscience

JF - Oncoscience

ER -

A predictive signature for therapy assignment and risk assessment in prostate cancer

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo